Sign up
UroToday – GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.
UroToday – GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.
Zachary Klaassen hosts Mark Tyson, Aimee Boden, and Meghann Davis, to discuss the implementation of Adstiladrin treatment in the clinic setting. They discuss the logistics…
The move by the California Supreme Court to review the case is seen as “very important,” according Evercore ISI analyst Umer Raffat.
Sam Chang hosts David Penson to shed light on the anticipated AUA 2024 meeting in San Antonio, focusing on the fresh, innovative sessions designed to…
A USDA analysis shows the spread in cattle started from a single spillover event from birds in the Texas panhandle that may have happened in…
Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, the Swiss drug…
Alicia Morgans presents a meta-analysis, undertaken with colleagues, analyzing 14 phase three trials on treatment intensification in metastatic hormone-sensitive prostate cancer. The study scrutinizes outcomes…
Alicia Morgans discusses her diverse roles at Dana-Farber, where she primarily treats prostate cancer patients, guiding them through various stages of their disease. Beyond patient…
Peyronie’s Disease, H100 Gel, Transdermal Application of H100 Gel, Peyronie’s Disease treatment, Peyronie’s Disease side effect treatment, tunica albuginea infiltration, tunica albuginea infiltration of H100.
When healthcare practices scale rapidly, they tend to accumulate an unruly, disharmonious tech stack that can complicate administrative, communication and marketing efforts.
This report describes the widening gap in preventable early deaths between rural and urban areas.